- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01280279
Necessity for Repetitive Education of Behavioral Modification
January 19, 2011 updated by: Seoul National University Hospital
Short-term Effects of Systematized Behavioral Modification Program (SBMP) for Nocturia: A Prospective Study
Few studies have reported the efficacy of repetitive education for behavioral modification as the first-line therapy for patients with nocturnal polyuria (NPU).
The aim of this study is to investigate the efficacy of repetitive education for behavioral modification as the first-line therapy in the patients with NPU and to show whether a single education for behavioral modification is sufficient for the patients.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Even though behavioral modification therapy seems to be effective, it is not usually recommended for patients with nocturia because much patience and understanding is required for the patients to follow the therapy.
Few studies have reported the efficacy of repetitive education for behavioral modification as the first-line therapy for patients with nocturia and nocturnal polyuria (NPU).
Furthermore, no report demonstrated the evidence about how many times or how long the education for behavioral therapy should be performed and how long will the education effect would continue.
The aim of this study is to investigate the efficacy of repetitive education for behavioral modification as the first-line therapy in the patients with NPU and to show whether a single education for behavioral modification is sufficient for the patients.
Study Type
Observational
Enrollment (Actual)
104
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who had the urine volume at nighttime more than one third of total daily urine volume (NPU) and voided more than two times at nighttime (nocturia)
Description
Inclusion Criteria:
- the urine volume at nighttime more than one third of total daily urine volume
- voided more than two times at nighttime
Exclusion Criteria:
- postvoid urine volume more than 100 ml
- sleep disturbance including sleep apnea
- diabetes mellitus
- diabetes insipidus
- neurogenic bladder
- congestive heart failure
- indwelling catheters
- urinary tract infection or urinary stones
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
group with nocturnal polyuria and nocturia
Patients were enrolled when they had the urine volume at nighttime more than one third of total daily urine volume (NPU) and voided more than two times at nighttime (nocturia)
|
a systematized 30-minutes education program for behavioral modification (SBMP) by watching videos and discussion with a specialized continence nurse practitioner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
decrease of nocturnal urine volume
Time Frame: 1 month after education
|
The variables of FVC were prospectively collected at the time of the first visit using frequency-volume chart (FVC) for 2 days.
On their second visit two weeks later, if they had nocturnal polyuria, they received the first education for behavioral modification and to fill up FVC again.
When they had no improvement of nocturnal polyuria on the third visit one month later, they finally received the second education and they were recommended to fill up the FVC.
|
1 month after education
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement of symptoms and quality of life
Time Frame: 1 month after education
|
The variables of FVC were prospectively collected at the time of the first visit using frequency-volume chart (FVC) for 2 days.
On their second visit two weeks later, if they had nocturnal polyuria, they received the first education for behavioral modification and to fill up questionnaires again.
When they had no improvement of nocturnal polyuria on the third visit one month later, they finally received the second education and they were recommended to fill up the FVC and questionnaires.
|
1 month after education
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Sung Yong Cho, M.D., Seoul National University Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
January 1, 2011
Study Registration Dates
First Submitted
January 17, 2011
First Submitted That Met QC Criteria
January 19, 2011
First Posted (Estimate)
January 20, 2011
Study Record Updates
Last Update Posted (Estimate)
January 20, 2011
Last Update Submitted That Met QC Criteria
January 19, 2011
Last Verified
January 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- nocturiaact
- nocturiabehavior
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on education for behavioral modification
-
Roswell Park Cancer InstituteCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Richard Ronan MurphyCompletedDementia Alzheimers | Disruptive BehaviorUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)CompletedInsomnia | Cancer Survivor | Malignant NeoplasmUnited States
-
National Institute of Diabetes and Digestive and...University of Massachusetts, WorcesterCompleted
-
Liberty UniversityNational Academy of Sports MedicineCompletedPostural; DefectUnited States
-
Chiang Mai UniversityCompletedHypertension | Postmenopausal SyndromeThailand
-
Tel Aviv UniversityCompleted
-
Eunice Kennedy Shriver National Institute of Child...National Center for Research Resources (NCRR)Unknown
-
Gary MorrowNational Cancer Institute (NCI); Stanford UniversityCompletedSleep Disorder | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIIC Breast CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States